Retrieve available abstracts of 5 articles: HTML format
Single Articles
July 2025
RIEGER C, Schluchtermann J, Heidenreich J, Steenbock O, et al Cost-effectiveness analysis of perioperative durvalumab plus platin-based
chemotherapy in muscle invasive bladder cancer in Germany.
Eur J Cancer. 2025;227:115621. PubMedAbstract available
May 2025
DUWE G, Mercier D, Kauth V, Moench K, et al Development of an artificial intelligence-generated, explainable treatment
recommendation system for urothelial carcinoma and renal cell carcinoma to
support multidisciplinary cancer conferences.
Eur J Cancer. 2025;220:115367. PubMedAbstract available
October 2024
OZBAY MF, Ilhan Y Letter Re: High serum sodium predicts immunotherapy response in metastatic renal
cell and urothelial carcinoma.
Eur J Cancer. 2024;210:114254. PubMed
August 2024
HONG H, Qu Y Letter re: High serum sodium predicts immunotherapy response in metastatic renal
cell and urothelial carcinoma.
Eur J Cancer. 2024;207:114173. PubMed
April 2023
CHUNG R, McKiernan J, Arpaia N, Marabelle A, et al Neo-Adjuvant immunotherapies: Bladder cancer as a platform for drug development
targeting mucosal immunity.
Eur J Cancer. 2023;187:58-64. PubMedAbstract available